Venture investments in infectious disease companies in the U.S. from 2006 to 2018
(in million U.S. dollars)
U.S. venture investments in infectious disease companies 2006-2018
In 2018, venture investments in infectious disease companies totaled some 372 million dollars. This was a significant decrease from the preceding year when venture investments had reached almost one billion dollars.
Venture investments in infectious disease companies in the U.S. from 2006 to 2018
(in million U.S. dollars)
Venture investments in million U.S. dollars
2018372
2017959
2016782
2015574
2014535
2013350
2012167
2011383
2010323
2009452
2008*435
2007*596
2006*522
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2019

Region

United States

Survey time period

2006 to 2018

Supplementary notes

* Added from previous editions of the same report.

U.S. venture investments in infectious disease companies 2006-2018
In 2018, venture investments in infectious disease companies totaled some 372 million dollars. This was a significant decrease from the preceding year when venture investments had reached almost one billion dollars.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.